These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26886329)

  • 1. Solid Phospholipid Dispersions for Oral Delivery of Poorly Soluble Drugs: Investigation Into Celecoxib Incorporation and Solubility-In Vitro Permeability Enhancement.
    Fong SY; Martins SM; Brandl M; Bauer-Brandl A
    J Pharm Sci; 2016 Mar; 105(3):1113-23. PubMed ID: 26886329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solubility enhancement of BCS Class II drug by solid phospholipid dispersions: Spray drying versus freeze-drying.
    Fong SY; Ibisogly A; Bauer-Brandl A
    Int J Pharm; 2015 Dec; 496(2):382-91. PubMed ID: 26468038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dynamic in vitro permeation study on solid mono- and diacyl-phospholipid dispersions of celecoxib.
    Jacobsen AC; Elvang PA; Bauer-Brandl A; Brandl M
    Eur J Pharm Sci; 2019 Jan; 127():199-207. PubMed ID: 30408522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and evaluation of celecoxib-loaded proliposomes with high lipid content.
    Jeon D; Kim KT; Baek MJ; Kim DH; Lee JY; Kim DD
    Eur J Pharm Biopharm; 2019 Aug; 141():139-148. PubMed ID: 31150807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipid-based solid drug formulations for oral bioavailability enhancement: A meta-analysis.
    Fong SY; Brandl M; Bauer-Brandl A
    Eur J Pharm Sci; 2015 Dec; 80():89-110. PubMed ID: 26296863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced oral delivery of celecoxib via the development of a supersaturable amorphous formulation utilising mesoporous silica and co-loaded HPMCAS.
    Lainé AL; Price D; Davis J; Roberts D; Hudson R; Back K; Bungay P; Flanagan N
    Int J Pharm; 2016 Oct; 512(1):118-125. PubMed ID: 27543354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Employment of Alginate Floating
    Abdul Rasool BK; Khalifa A; Abu-Gharbieh E; Khan R
    Biomed Res Int; 2020; 2020():1879125. PubMed ID: 32596281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amorphous Salts Solid Dispersions of Celecoxib: Enhanced Biopharmaceutical Performance and Physical Stability.
    Mukesh S; Joshi P; Bansal AK; Kashyap MC; Mandal SK; Sathe V; Sangamwar AT
    Mol Pharm; 2021 Jun; 18(6):2334-2348. PubMed ID: 34003656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colon targeting of celecoxib nanomixed micelles using pulsatile drug delivery systems for the prevention of inflammatory bowel disease.
    El-Hady SM; AbouGhaly MHH; El-Ashmoony MM; Helmy HS; El-Gazayerly ON
    Int J Pharm; 2020 Feb; 576():118982. PubMed ID: 31870958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do Phospholipids Boost or Attenuate Drug Absorption? In Vitro and In Vivo Evaluation of Mono- and Diacyl Phospholipid-Based Solid Dispersions of Celecoxib.
    Jacobsen AC; Ejskjær L; Brandl M; Holm R; Bauer-Brandl A
    J Pharm Sci; 2021 Jan; 110(1):198-207. PubMed ID: 32827494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biopharmaceutical classification of poorly soluble drugs with respect to "enabling formulations".
    Buckley ST; Frank KJ; Fricker G; Brandl M
    Eur J Pharm Sci; 2013 Sep; 50(1):8-16. PubMed ID: 23583787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid Crystalline Systems Based on Glyceryl Monooleate and Penetration Enhancers for Skin Delivery of Celecoxib: Characterization, In Vitro Drug Release, and In Vivo Studies.
    Dante MCL; Borgheti-Cardoso LN; Fantini MCA; Praça FSG; Medina WSG; Pierre MBR; Lara MG
    J Pharm Sci; 2018 Mar; 107(3):870-878. PubMed ID: 29108729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ intestinal permeability and in vivo oral bioavailability of celecoxib in supersaturating self-emulsifying drug delivery system.
    Song WH; Yeom DW; Lee DH; Lee KM; Yoo HJ; Chae BR; Song SH; Choi YW
    Arch Pharm Res; 2014 May; 37(5):626-35. PubMed ID: 23852645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoemulsion: a promising tool for solubility and dissolution enhancement of celecoxib.
    Shakeel F; Faisal MS
    Pharm Dev Technol; 2010; 15(1):53-6. PubMed ID: 19552546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amorphous multi-system of celecoxib improves its anti-inflammatory activity in vitro and oral absorption in rats.
    Choi JS; Ahn JB; Park JS
    Int J Pharm; 2019 Jan; 555():135-145. PubMed ID: 30458259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-existing colloidal phases in artificial intestinal fluids assessed by AF4/MALLS and DLS: A systematic study into cholate & (lyso-) phospholipid blends, incorporating celecoxib as a model drug.
    Elvang PA; Jacobsen AC; Bauer-Brandl A; Stein PC; Brandl M
    Eur J Pharm Sci; 2018 Jul; 120():61-72. PubMed ID: 29704643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Facile Strategy to Generate High Drug Payload Celecoxib Micelles for Enhanced Corneal Permeability.
    Bao Z; Zhou Y; Lei L; Zhang R; Song Q; Li X; Wang Y
    J Biomed Nanotechnol; 2019 Apr; 15(4):822-829. PubMed ID: 30841974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Freeze dried solid dispersion of exemestane: A way to negate an aqueous solubility and oral bioavailability problems.
    Kaur S; Jena SK; Samal SK; Saini V; Sangamwar AT
    Eur J Pharm Sci; 2017 Sep; 107():54-61. PubMed ID: 28663037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro and In Vivo Evaluation of Core-Shell Mesoporous Silica as a Promising Water-Insoluble Drug Delivery System: Improving the Dissolution Rate and Bioavailability of Celecoxib With Needle-Like Crystallinity.
    Han C; Zhang S; Huang H; Dong Y; Sui X; Jian B; Zhu W
    J Pharm Sci; 2019 Oct; 108(10):3225-3232. PubMed ID: 31226426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of polymer molecular weight on in vitro dissolution behavior and in vivo performance of celecoxib:PVP amorphous solid dispersions.
    Knopp MM; Nguyen JH; Becker C; Francke NM; Jørgensen EB; Holm P; Holm R; Mu H; Rades T; Langguth P
    Eur J Pharm Biopharm; 2016 Apr; 101():145-51. PubMed ID: 26899127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.